Alps Advisors Inc Xencor Inc Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in Xencor Inc stock. As of the latest transaction made, Alps Advisors Inc holds 48,083 shares of XNCR stock, worth $983,297. This represents 0.01% of its overall portfolio holdings.

Number of Shares
48,083
Previous 48,097 0.03%
Holding current value
$983,297
Previous $910,000 6.15%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$15.7 - $21.65 $219 - $303
-14 Reduced 0.03%
48,083 $966,000
Q2 2024

Aug 13, 2024
BUY
$18.21 - $24.5 $90,886 - $122,279
4,991 Added 11.58%
48,097 $910,000
Q1 2024

May 14, 2024
BUY
$18.65 - $26.52 $53,749 - $76,430
2,882 Added 7.16%
43,106 $953,000
Q4 2023

Feb 14, 2024
SELL
$16.53 - $21.42 $74,037 - $95,940
-4,479 Reduced 10.02%
40,224 $853,000
Q3 2023

Nov 14, 2023
BUY
$20.08 - $25.39 $6,244 - $7,896
311 Added 0.7%
44,703 $900,000
Q2 2023

Aug 14, 2023
BUY
$24.77 - $29.9 $119,862 - $144,686
4,839 Added 12.23%
44,392 $1.11 Million
Q1 2023

May 10, 2023
SELL
$25.95 - $36.95 $27,688 - $39,425
-1,067 Reduced 2.63%
39,553 $1.1 Million
Q4 2022

Feb 14, 2023
BUY
$24.79 - $30.86 $199,757 - $248,669
8,058 Added 24.75%
40,620 $1.06 Million
Q3 2022

Nov 14, 2022
SELL
$24.62 - $32.44 $67,901 - $89,469
-2,758 Reduced 7.81%
32,562 $846,000
Q2 2022

Aug 11, 2022
BUY
$19.74 - $29.01 $697,216 - $1.02 Million
35,320 New
35,320 $967,000
Q1 2022

May 16, 2022
SELL
$26.68 - $41.63 $1.81 Million - $2.82 Million
-67,679 Closed
0 $0
Q4 2021

Feb 09, 2022
SELL
$33.67 - $43.44 $128,114 - $165,289
-3,805 Reduced 5.32%
67,679 $2.72 Million
Q3 2021

Nov 15, 2021
SELL
$30.65 - $35.68 $144,055 - $167,696
-4,700 Reduced 6.17%
71,484 $2.34 Million
Q2 2021

Aug 11, 2021
SELL
$34.33 - $44.68 $983,348 - $1.28 Million
-28,644 Reduced 27.32%
76,184 $2.63 Million
Q1 2021

May 07, 2021
BUY
$40.81 - $53.88 $55,583 - $73,384
1,362 Added 1.32%
104,828 $4.51 Million
Q4 2020

Feb 03, 2021
BUY
$36.63 - $47.63 $3.79 Million - $4.93 Million
103,466 New
103,466 $4.51 Million

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.5M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.22B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email